bullish
Taisho 1H FY18 (YE Mar'19) Results - First Glance
305 Views29 Oct 2018 20:58
Key highlights
“Prescription pharma” segment (-15.1% to ¥~40b) lead overall sales decline by 6.6% to ¥129.5b
Y-o-y decrease in SG&A and R&D...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
x